(Q88184732)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29582190%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

title

Evaluation of efficacy of infliximab for retinal vasculitis and extraocular symptoms in Behçet disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29582190%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference

Akihiko Umazume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29582190%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Takeshi Kezuka

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29582190%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Yoshihiko Usui

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29582190%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Jun Suzuki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29582190%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Hiroshi Goto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29582190%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

publication date

26 March 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29582190%20AND%20SRC:MED&resulttype=core&format=json

Japanese Journal of Ophthalmology

21 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29582190%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29582190%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29582190%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

390-397

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29582190%20AND%20SRC:MED&resulttype=core&format=json

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

21 March 2020

cites work

1 reference

12 December 2020

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

1 reference

12 December 2020

Posterior segment involvement in ocular Behçet's disease.

1 reference

12 December 2020

Fluorescein and indocyanine green angiography findings in Behçet's disease

1 reference

12 December 2020

Indocyanine green and fundus fluorescein angiographic findings in patients with active ocular Behcet's disease

1 reference

12 December 2020

Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey

1 reference

12 December 2020

Current concepts in the etiology and treatment of Behçet disease

1 reference

12 December 2020

Risk and prognostic factors of poor visual outcome in Behcet's disease with ocular involvement

1 reference

12 December 2020

Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab

1 reference

12 December 2020

Serious adverse events with infliximab: analysis of spontaneously reported adverse events

1 reference

12 December 2020

Behçet's disease: ocular effects and treatment

1 reference

12 December 2020

Effects of infliximab in the treatment of refractory posterior uveitis of Behçet’s disease after withdrawal of infusions

1 reference

12 December 2020

Relationship between serum infliximab levels and acute uveitis attacks in patients with Behcet disease

1 reference

12 December 2020

Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study

1 reference

12 December 2020

Correlation between elevation of serum antinuclear antibody titer and decreased therapeutic efficacy in the treatment of Behçet's disease with infliximab

1 reference

12 December 2020

Down-titration and discontinuation of infliximab in rheumatoid arthritis patients with stable low disease activity and stable treatment: an observational cohort study

1 reference

12 December 2020

Multicenter study of infliximab for refractory uveoretinitis in Behçet disease

1 reference

12 December 2020

Current and future treatments for Behçet's uveitis: road to remission

1 reference

12 December 2020

Long-term clinical outcomes in patients with refractory uveitis associated with Behçet disease treated with infliximab.

1 reference

12 December 2020

Clinical course of patients with Behçet's uveitis following discontinuation of infliximab therapy

1 reference

12 December 2020

Is it possible to withdraw biologics from therapy in rheumatoid arthritis?

1 reference

12 December 2020

Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders

1 reference

12 December 2020

Behçet's disease ocular attack score 24: evaluation of ocular disease activity before and after initiation of infliximab

1 reference

12 December 2020

Long-term progression of retinal vasculitis in Behçet patients using a fluorescein angiography scoring system

1 reference

12 December 2020

Outcome after discontinuation of TNFα-blocking therapy in patients with inflammatory bowel disease in deep remission

1 reference

12 December 2020

Long-term efficacy of infliximab on background vascular leakage in patients with Behçet's disease

1 reference

12 December 2020

Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behçet's disease: a multicenter study.

1 reference

12 December 2020

Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis

1 reference

12 December 2020

Early treatment with infliximab in bilateral occlusive vasculitis as a presenting manifestation of Behçet' disease.

1 reference

12 December 2020

Adverse events resulting in withdrawal of biologic therapy for psoriasis in real-world clinical practice: A Canadian multicenter retrospective study

1 reference

12 December 2020

Correlation between Fluorescein Angiographic Findings and Visual Acuity in Behçet Retinal Vasculitis.

1 reference

12 December 2020

Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients

1 reference

12 December 2020

Biological therapies (immunomodulatory drugs), worsening of psoriasis and rebound effect: new evidence of similitude

1 reference

12 December 2020

10.1007/S10384-018-0589-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29582190%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference